Pegvisomant And Sandostatin LAR Combination Study

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

May 31, 2006

Conditions
Acromegaly
Interventions
DRUG

Pegvisomant/ Sandostatin LAR

DRUG

Sandostatin LAR

DRUG

Pegvisomant

Trial Locations (33)

2010

Pfizer Investigational Site, Darlinghurst

3165

Pfizer Investigational Site, Fitzroy

Pfizer Investigational Site, Fizroy

10117

Pfizer Investigational Site, Berlin

16132

Pfizer Investigational Site, Genova

20162

Pfizer Investigational Site, Milan

22908

Pfizer Investigational Site, Charlottesville

28035

Pfizer Investigational Site, Madrid

34295

Pfizer Investigational Site, Montpellier

90048

Pfizer Investigational Site, Los Angeles

98122

Pfizer Investigational Site, Messina

02114

Pfizer Investigational Site, Boston

27599-7600

Pfizer Investigational Site, Chapel Hill

21941-590

Pfizer Investigational Site, Rio de Janeiro

05403-060

Pfizer Investigational Site, São Paulo

B3H 1V7

Pfizer Investigational Site, Halifax

B3H 2Y9

Pfizer Investigational Site, Halifax

M5G 1X5

Pfizer Investigational Site, Toronto

06202

Pfizer Investigational Site, Nice

01307

Pfizer Investigational Site, Dresden

Unknown

Pfizer Investigational Site, Hanover

Pfizer Investigational Site, Torino

06720

Pfizer Investigational Site, Mexico City

02990

Pfizer Investigational Site, Col La Raza

6500 GA

Pfizer Investigational Site, Nijmegen

0027

Pfizer Investigational Site, Oslo

08906

Pfizer Investigational Site, L'Hospitalet de Llobregat

BT12 6BA

Pfizer Investigational Site, Belfast

LS1 3EX

Pfizer Investigational Site, Leeds

EC1A 7BE

Pfizer Investigational Site, London

SE1 7EH

Pfizer Investigational Site, London

M20 4BX

Pfizer Investigational Site, Manchester

OX3 7LJ

Pfizer Investigational Site, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY